The NCCN Guidelines for Kidney Cancer focus on the screening, diagnosis, staging, treatment, and management of renal cell carcinoma (RCC). Patients with relapsed or stage IV RCC typically undergo surgery and/or receive systemic therapy. Tumor histology and risk stratification of patients is important in therapy selection. The NCCN Guidelines for Kidney Cancer stratify treatment recommendations by histology; recommendations for first-line treatment of ccRCC are also stratified by risk group. To further guide management of advanced RCC, the NCCN Kidney Cancer Panel has categorized all systemic kidney cancer therapy regimens as "Preferred," "Other Recommended Regimens," or "Useful in Certain Circumstances." This categorization provides guidance on treatment selection by considering the efficacy, safety, evidence, and other factors that play a role in treatment selection. These factors include pre-existing comorbidities, nature of the disease, and in some cases consideration of access to agents. This article summarizes surgical and systemic therapy recommendations for patients with relapsed or stage IV RCC.
Journal of the National Comprehensive Cancer Network : JNCCN. 2022 Jan [Epub]
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Michael Baine, Kathryn Beckermann, Maria I Carlo, Toni K Choueiri, Brian A Costello, Ithaar H Derweesh, Arpita Desai, Yasser Ged, Saby George, John L Gore, Naomi Haas, Steven L Hancock, Payal Kapur, Christos Kyriakopoulos, Elaine T Lam, Primo N Lara, Clayton Lau, Bryan Lewis, David C Madoff, Brandon Manley, M Dror Michaelson, Amir Mortazavi, Lakshminarayanan Nandagopal, Elizabeth R Plimack, Lee Ponsky, Sundhar Ramalingam, Brian Shuch, Zachary L Smith, Jeffrey Sosman, Mary A Dwyer, Lisa A Gurski, Angela Motter
Memorial Sloan Kettering Cancer Center., The University of Texas MD Anderson Cancer Center., Huntsman Cancer Institute at the University of Utah., University of Michigan Rogel Cancer Center., Fred & Pamela Buffet Cancer Center., Vanderbilt-Ingram Cancer Center., Dana-Farber/Brigham and Women's Cancer Center., Mayo Clinic Cancer Center., UC San Diego Moores Cancer Center., UCSF Helen Diller Family Comprehensive Cancer Center., The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Roswell Park Comprehensive Cancer Center., Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance., Abramson Cancer Center at the University of Pennsylvania., Stanford Cancer Institute., UT Southwestern Simmons Comprehensive Cancer Center., University of Wisconsin Carbone Cancer Center., University of Colorado Cancer Center., UC Davis Comprehensive Cancer Center., City of Hope National Medical Center., Kidney Cancer Coalition., Yale Cancer Center/Smilow Cancer Hospital., Moffitt Cancer Center., Massachusetts General Hospital Cancer Center., The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., O'Neal Comprehensive Cancer Center at UAB., Fox Chase Cancer Center., Case Comprehensive Cancer Center/ University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Duke Cancer Institute., UCLA Jonsson Comprehensive Cancer Center., Siteman Cancer Center at Barnes- Jewish Hospital and Washington University School of Medicine., Robert H. Lurie Comprehensive Cancer Center of Northwestern University., National Comprehensive Cancer Network.